Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01, Clinical Trial Optional)

Funder: National Institutes of Health

Due Date: 9/7/2018

Budget: Negotiable

Opportunity: PA-18-465

The purpose of this Funding Opportunity Announcement (FOA) is to support projects that will elucidate the therapeutic potential of the cannabinoids and endocannabinoid system in the development of mechanism-based therapies for pain.

Leave a Reply